tion will reduce morbidit y and mortality associated with cardiovascular disease, thus reducing the economic burden and facilitating employees' return to work.
ETIOLOGY OF ISCHEMIC HEART DISEASE
The heart muscle or myocardium receives its blood supply through the coronary arteries. The coronary arteries originate through an opening in the aorta called the coronary ostia. They divide to form four major branches : left coronary artery, left anterior descending artery, circumflex artery, and right coronary artery (McCance, 1996) . Ischemic heart disease (IHD) is the imbalance between the supply and the demand of the myocardium for oxygen and nutrients. The narrowing or obstruction of the coronary arteries is the most common cause of myocardial ischemia. Therefore , the terms coronary artery disease (CAD) or coronary heart disease (CHD) are often used to describe this disease (Schoen, 1994a) .
Atherosclerosis is a disease of the arterial system characterized by deposits of fat and fibrin on the intima (or innermost ) layer of the vessel. Over time the smooth muscle cells and collagen fibers that have accumulated cause the vessel to thicken and become stiff (Haak, 1996) . The earliest sign of atherosclerotic lesions, the fatty streak, has been observed in children, some younger than 1 year of age (Schoen, 1994b) . Fibrous plaques characterize the more advanced lesions of atherosclerosis. Fibrous plaques have a core of lipids and are covered by fibrous caps. In smaller arteries the plaque protrudes into the lumen, compromising blood flow distal to the obstruction. In larger arteries the plaque tends to be unstable, which may lead to plaque rupture and thrombosis (Schoen, 1994b) . Plaque rupture may occur as a result of shear stress from increased blood pressure. In addition, it has recently been postulated that acute inflamma-tory processes may play a role in plaque development and plaque rupture (Dzau, 1994) .
The risk factors that increase an individual's susceptibility for IHD and atherosclerosis have been well documented. A risk factor is a condition demonstrated by statistical procedures to increase the susceptibility of an individual to the morbidity and mortality of IHD (Gotto, 1988) . Cardiovascular risk factors generally are divided into two categories: those that can and those that cannot be modified. Modifiable risk factors include smoking, hypertension, hyperlipidemia, lack of exercise, obesity, alcohol, and psychological response to stress. Non-modifiable risk factors include a positive family history for IHD, diabetes, male gender, and increased age. The goals of risk factor reduction include the prevention of disease, delaying onset of symptoms, and slowing the progression of disease (Cunningham, 1988) . Health professionals recognize that primary prevention, with an emphasis on public education, is the most cost effective method of reducing morbidity and mortality of IHD. Unfortunately, even individuals with IHD remain ignorant of their personal risks (Zerwic, 1997) . The ability to recognize one's own risk profile may be a necessary first step toward initiating modification of risk factors.
PATHOPHYSIOLOGY OF MYOCARDIAL ISCHEMIA
Under normal conditions the coronary arteries provide sufficient oxygen to meet the demands of the myocardium, compensating for increased demand by vasodilating the arteries. In certain situations the body is unable to supply an adequate amount of oxygen to the tissues, which results in ischemia. Ischemia is a temporary or reversible state resulting in myocardial dysfunction. Ischemia is caused by decreased oxygen supply to the myocardium or increased myocardial oxygen demand. Factors that may decrease oxygen supply include hypotension, decreased blood volume, or increased resistance in the coronary vessels (Haak, 1996) . An increased oxygen demand can occur as a result of a number of factors, including increased heart rate from exercise or stress, high systolic pressure, or increased thickness of the myocardium. Myocardial ischemia is most often caused by atherosclerosis which reduces the size of the arterial lumen, compromising blood flow. Individuals may not have symptoms of ischemia until 75% of the artery lumen is occluded.
Angina Pectoris
Angina pectoris is the discomfort in the chest caused by myocardial ischemia. Angina is associated with myocardial disturbance, but does not result in myocardial necrosis (cell death) if blood flow is restored. The site of the discomfort is usually retrosternal and may radiate to a number of locations including the ulnar aspect of the left arm, the neck, and jaw. Anginal equivalent is the term used to describe symptoms of myocardial ischemia other than angina and may include dyspnea, fatigue, and dizziness. Angina is usually brief in duration, lasting 3 to 5 minutes (Haak, 1996) . Not all 196 episodes of ischemia are recognized by clients. Thus, these events are described as silent ischemia.
Angina is classified as stable, unstable, or Prinzmetals angina. Stable angina is the result of narrowing of the arterial lumen and an inability of the vessel to dilate in response to an increased demand for oxygen. Stable angina usually is triggered by physical exertion and is relieved by either rest (decreasing oxygen demand) or nitroglycerine (a vasodilator that increases oxygen supply). In contrast, unstable angina is characterized by symptoms at rest or minimal exertion, or angina that is more severe, prolonged, or frequent than past episodes. Unstable angina may be a warning of impending infarction (Haak, 1996) , requiring prompt evaluation and therapy. Prinzmetals or variant angina is a form of angina triggered by vasospasm of one or more of the coronary arteries. It mayor may not be associated with atherosclerosis and often occurs during rest or sleep. Prinzmetals angina is usually treated with vasodilators such as nitroglycerine and calcium channel blockers.
Acute Myocardial Infarction AMI is prolonged myocardial ischemia resulting in irreversible cellular injury and cell death. The primary mechanism responsible for AMI has been shown to be a thrombosis which occludes the lumen of the coronary artery. DeWood (1980) performed coronary angiography in individuals shortly after the onset of AMI symptoms and demonstrated that 90% of the individuals had evidence of thrombosis in the coronary artery. In the majority of cases the thrombosis occurred as a result of rupture of the atheromatous plaque (Dzau, 1994) . The rupture of this plaque exposes the contents of the plaque to the circulation. When the fat laden macrophages contained within the plaque are exposed to the circulation, platelets begin to aggregate, forming a thrombus over the site of the plaque. Platelets also release substances that cause vasoconstriction. Thus, coronary arteries that have nonsignificant obstruction can rapidly progress to critical stenosis and infarction as a result of the mechanism of plaque rupture, thrombosis, and vasospasm (Dzau, 1994) .
Diagnosis. To document the diagnosis of AMI, practitioners will examine whether the client presents with one or more of the following (Califf, 1992) :
• Clinical symptoms compatible with acute ischemia, • ECG abnormalities, • Pattern of cardiac enzyme release typical for myocardial ischemia. The primary symptom compatible with acute ischemia is chest pain or chest discomfort that lasts longer than 20 minutes and is not relieved with rest or nitroglycerin. The pain may be described as a mild aching to severe, crushing, "vice like" discomfort. It is typically located in the retrosternal area and may radiate to the left or right arm, shoulder, throat, and/or jaw area. Frequent associated symptoms of AMI are diaphoresis, pallor, indigestion, nausea, dyspnea, weakness, dizziness, and syncope. Any or all of the forgoing symptoms may be reported. In addition, the intensity of the associated symptoms may mask the client's perception of chest discomfort and serve as the client 's presenting complaint. For example, an individual presenting with "shortness of breath" may admit to retrosternal chest discomfort with further questioning .
The electrocardiogram (ECG) is a reflection of the electrical impulse as it travels through the heart. Each of the 12 leads (I, II, III, aVR, aVL, aVF, VI-V6) provides a picture of the electrical activity as it passes through a specific part of the myocardium. In most clients, changes can be identified on the ECG as the myocardium becomes ischemic . The leads that reflect the changes correspond to the area of the heart experiencing the ischemia and provide information about the occluded vessel (see Table 1 ). For example, changes observed in leads V1-V4 correspond to the anterior area of the heart. The anterior area of the heart is supplied by the left anterior descending artery.
The changes on the ECG corresponding to myocardial ischemia and infarction include T wave inversion (ischemia), ST segment elevation (injury), and pathological Q waves (necrosis) in the ECG leads over the area of infarct (see Figure) . A pathological Q wave is an initial downward deflection of the QRS complex which is 4 mm in depth and >0.04 seconds in duration. The leads over the opposite wall of the infarct may demonstrate what are called reciprocal changes: ST segment depression, tall R waves, and tall T waves (Conover, 1994) .
Pathological Q waves are present in about 65% to 75% of all cases of infarction. Non-Q wave myocardial infarctions may occur as a result of incomplete occlusion of the vessel or damage to the heart which did not extend through all layers of the muscle. If Q waves are present, these changes persist indefinitely on an individual's ECG. In contrast, ST segment elevation and depression is a transient finding on ECG and usually resolves within a few hours to a few days after infarction.
Irreversibly damaged myocardial cells release a number of enzymes into the blood stream where they can be measured. Creatine kinase (CK) and the iso-enzyme CK-MB are enzymes specific to myocardial tissue. An elevation in CK-MB can be identified within 4 to 8 hours after the onset of AMI. Over a 3 day period, the CK-MB makes a very predictable rise and fall, with a peak level APRIL 1998, VOL. 46, NO.4 occurring 24 hours after the onset of AMI. An increase in the CK-MB of >5% of the total CK reflects myocardial injury (Goe, 1995) . Lactate dehydrogenase (LDH) is another measurable enzyme which serves to confirm the diagnosis of AMI in conjunction with the CK-MB. LDH levels begin to increase about 12 to 48 hours following AMI, peaking at 48 to 72 hours, and returning to normal in 7 days. Alternative laboratory markers have recently been identified which allow for a more rapid identification of AMI, such as Troponin T and Troponin I.
It is important that serial ECGs and card iac enzymes are obtained during the first 24 hours after symptoms to examine the patterns in the tests ' results . The initial result may not be diagnostic if it was obtained early after the onset of symptoms, yet may provide a baseline for comparison.
Complications. Irreversible myocardial damage and cellular death begin to occur within 20 to 40 minutes following occlusion (Kumar, 1992) . The consequences of AMI are a function of the extent and the area of the myocardium affected by the occluded coronary artery. Within minutes after the onset of severe ischemia, the contractility of the heart is compromised (Schoen , 1994a) . This results in left ventricular failure associated with some degree of hypotension, pulmonary vascular congestion, and leaking of fluid into the pulmonary spaces. This failure may range from mild to severe pulmonary edema. Significant myocardial dysfunction leading to cardiogenic shock occurs in 10% off all AMI clients and generally indicates that a large amount of myocardial tissue was affected (Schoen, 1994a) .
Over 90% of all individuals experience rhythm disturbances after AMI owing to the irritability of the myocardial tissue (Haak, 1996) . The rhythm problems commonly identified are sinus bradycardia, heart block, sinus tachycardia, premature ventricular contractions, ventricular tachycardia, and ventricular fibrillation. Sudden cardiac death (unexpected cardiac death within the first hour after initiation of an ischemic event) is a leading cause of mortality in AMI clients and is usually due to ventricular fibrillation or asystole. Sudden cardiac death is a rhythm disturbance which results in ineffective contraction of the ventricles. Inadequate perfusion >5 minutes results in irreversible brain damage. Acute myocardial infarction may cause sudden cardiac death or a cardiac arrest. However, cardiac arrest can be initiated by a disease or event other than AMI (e.g., electrical shock).
A number of other complications may be experienced after infarction including pericarditis, cardiac rupture, and thromboembolism (Haack, 1996; Schoen, 1994a) . Pericarditis is an inflammation of the pericardial sac which surrounds the heart and is usually effectively managed with non-steroidal antiinflammatory agents. Various structures in the heart can rupture as a consequence of tissue necrosis and weakening of the tissue, including the papillary muscle, which is attached to the heart valves, the ventricular walls, or the septum, which separates the heart's chambers. Thromboembolism in the systemic circulation, particularly pulmonary emboli or deep venous thrombi, is a consequence of sluggish blood flow and immobilization.
Treatment. Prior to the mid-1980s, the focus of treatment for AMI was primarily pain relief and monitoring/treating complications as they occurred. However, treatment of AMI has changed dramatically since the development of thrombolytic therapy, percutaneous transluminal coronary angioplasty (PTCA), and coronary artery bypass graft (CABG) surgery. The current goal of treatment is focused on reestablishing the blood flow, and consequently the oxygen supply, to the heart muscle, thus limiting the infarction size.
Thrombolytics are medications administered intravenously to dissolve the thrombosis (blood clot). Dissolving the blood clot restores some or all of the blood flow to the area, thus limiting the extent of myocardial tissue necrosis. Although several thrombolytic agents are available, tissue plasminogen activator (t-PA), streptokinase, and anisoylated plasminogen streptokinase (APSAC) are the most commonly used agents. Considerations in choosing a particular thrombolytic include the expense of the medication, complications associated with the medications, reperfusion rates, and the client's health history.
Percutaneous transluminal coronary angioplasty (PTCA) also is used at the time of AMI. PTCA is a process where a thin wire catheter is guided into the heart through an artery. The wire is advanced to the area of obstruction, where a small balloon is inflated at the tip of the wire to open the blocked or narrowed vessel. PTCA has been used as a primary intervention in removing coronary thrombus.
Although used less often during the acute phase of AMI, CABG surgery is a procedure designed to improve blood flow to potentially compromised areas of the myocardium. CABG is a surgical procedure in which one or more vessels are attached proximal to and distally around an occluded site to provide an alternate path for blood flow to a given area. The AMI clients most likely to benefit from a CABG include: individuals experiencing an evolving AMI with cardiogenic shock; individuals who have had unsuccessful PTCA or thrombolytic therapy; individuals experiencing postinfarction angina when PTCA is unsuitable; and persons experiencing an occlusion during PTCA (Lavie, 1990) .
Whether an AMI is treated through pharmacologic (thrombolytics) or mechanical (PTCA) means, the critical component in successfully reducing morbidity and mortality is the ability to implement the therapy early after the onset of symptoms. Early initiation of therapy correlates to the first stage of tissue infarction (Califf, 1992) . As the time increases from AMI onset to initiation of reperfusion therapies, the benefits are reduced.
A number of other pharmacologic as well as nonpharmacologic therapies are implemented early in the course of the client's hospital admission. Aspirin (75 to 325 mg/day) impairs platelet aggregation by inactivating platelet cyclooxygenase and reducing the release of platelet derived vasoconstrictors. Heparin is an anticoagulant administered intravenously. Heparin increases the activity of antithrombin III inhibiting the conversion of prothrombin to thrombin, thereby inhibiting further thrombus formation. Beta blockers (e.g., atenolol, metoprolol) reduce myocardial oxygen demands by their ability to block cardiac stimulating effects of norepinephrine and epinephrine. Nitrates (nitroglycerine sublingual or intravenous) reduce end-diastolic pressure by relaxing vascular smooth muscle and dilating peripheral arterioles and veins, which increases blood flow to the endocardium. The sublingual tablets or metered sublingual spray serve as an effective means by which to administer a rapid dose and exert their effects for about 1 hour. Narcotics (morphine sulfate) may be used to relieve severe pain and discomfort and may reduce myocardial workload through vasodilatation. Angiotensin converting enzyme (ACE) inhibitors (i.e., captopril) are used for individuals with left Experiencing a Heart Attack at Work: Case Example "What I found it to be was like bad indigestion or heartburn that couldn't be cleared by burping or belching. Some kind of way to clear it. My heart attack was such that it just felt like it was pulling me in toward the heart. Almost like if your extremities are cold and all the blood rushes to keep the inner part of your body warm. That is what it felt like with the heart attack. Everything was rushing to the heart to keep that working and I felt tingling in my finger tips and underneath my arms. Really, really, tight in the chest. Sweaty. I was drenched in sweat and very nauseated.
"Last Wednesday I was at a meeting. I started to sweat really bad and feel nauseated. I knew there was something wrong...you know they always say that your heart affects the left side of your arm first, you get a pain in the left arm. I had a severe pain in my left arm, not my right arm, although there was tingling. A pain down my left one. The first pain I got was around 9:00. I didn't do anything. It kind of subsided fo.r a little while about 9:30. We broke for a coffee break at 10:00. I had a half a cup of coffee. I started to get severe pains which dissipated again. I sat down in the chair. We started up the meeting and I...went through a severe sweating spell, bad chest pains, and I said I had to go to the bathroom. Which I did. I vomited. I went back. I still had chest pains. I couldn't clear the chest pains and I went and asked to be taken to the hospital. They took me to the hospital and they took an EKG which showed I was going through a heart attack:' ,1993, unpublished data. ventricular dysfunction. ACE inhibitors interrupt the renin-angiotensin-aldosterone system which results in vasodilation and excretion of sodium and water. Supplemental oxygen therapy is usually routinely administered to clients an effort to increase the arterial oxygen tension and thereby increase myocardial oxygen supply. The American College of Cardiology and the American Heart Association (Ryan, 1996) recommend supplemental oxygen be provided to all clients initially suspected of having an AMI. Clients are placed on bedrest to reduce myocardial oxygen demand and closely monitored during the immediate course after myocardial infarction. ECG rhythm and indicators of hemodynamic status are observed to document trends and identify potential life threatening complications. Upon stabilization, the client begins a program in which physical activity is introduced in fairly rapid consecutive steps as long as no further symptoms are experienced.
Many individuals have further diagnostic testing prior to hospital discharge.A modified exercise stress test may be used to examine the presence of symptoms or ECG changes with exercise. A coronary angiogram may be conducted during hospitalization or at some point after discharge. The angiogram is a minimally invasiveprocedure in which a catheter is threaded through a femoral or brachial artery and dye is injected into the coronary arteries. The flow of dye through the coronary arteries allows visualization of the extent of any obstructions in the arteries.
While in the hospital, the client begins range of motion exercises and a walking program. These activities are increased daily in an incremental manner as the client tolerates. Upon discharge the client is instructed about daily activities that can be performed based on the client's response to exercise and walking. Typically the client is instructed to walk initially 10 to 15 minutes twice daily on a flat surface and to perform flexibility/stretching exercis- APRIL 1998, VOL. 46, NO.4 es, Home exercise instructions vary and need to be individualized. Following discharge, clients are referred to an outpatient cardiac rehabilitation program when possible. These programs provide education, support, monitoring, and individualized exercise. Clients typically attend three times per week and exercise using interval training for 30 to 45 minutes. Clients are monitored throughout the session and workloads are increased based on the individual's response. Many programs attempt to tailor some of the exercises to strengthen muscle groups frequently used in the work setting.
NURSING ROLE
The nurse in the workplace plays an important role in assessing and managing the employee who experiences AMI at the worksite. The nurse's goal is to quickly identify the possibility of AMI and triage that individual into the EMS.
The importance of the first hour after the onset of symptoms, often referred to as the "golden hour," cannot be over emphasized. Individuals receiving thrombolytics within 1 hour after the onset of symptoms are 50% more likely to survive the first year following AMI (ISIS-2, 1988) . Unfortunately, the typical delay between symptom onset and assessment is 2 to 12 hours (Dracup, 1995) . Such delays can significantly impact clients' recovery from AMI. The major portion of the delay can be attributed to the time it takes the individual to interpret the symptoms and make the decision to seek treatment. The Sidebar presents a. description of the sequence of events for one individual who experienced an AMI at work.
Triage
The nurse's assessment of the AMI client should concentrate on obtaining a brief but focused history. Clarify- The information obtained in this focused history helps the nurse determine if the symptoms appear to be indicative of myocardial ischemia or some other problem. For example, if the individual is able to localize the spot of discomfort on the chest by pointing with one finger, the pain is probably not due to ischemia. A number of different conditions can produce chest discomfort. Musculoskeletal conditions can produce pain originating in the chest wall. This pain may be aggravated by deep inspiration, cough, direct palpation, and movement (Goroll, 1995) . Inflammation of the pleura of the lungs results in a pleuritic pain which is increased with deep inspiration and cough, but is unaffected by palpation or movement. Esophageal or gastrointestinal conditions may be confused with cardiac symptoms. Esophageal reflux is characterized by a burning sensation, which often occurs after a meal, or lying down, and may be relieved with an antacid. The features that distinguish the symptoms associated with cardiac ischemia from other non-emergency types of problems are sometimes difficult to identify. AMI usually produces discomfort described as a pressure or heavy sensation, it often occurs in the retrosternal area, and may or may not radiate to one or both sides of the chest, the throat, jaw, shoulder(s), arm(s), and upper back. The discomfort of an angina episode may last 15 seconds to 15 minutes, while the symptoms of AMI last from 10 minutes to several hours. Other symptoms that may occur in conjunction with or in the place of chest discomfort during an AMI are dyspnea, fatigue, dizziness, syncope, diaphoresis, nausea, and vomiting.
Information about any past cardiac history, especially prior myocardial infarction or angina, is important to obtain. In addition, information about the presence of risk factors for ischemic heart disease is relevant. Individuals experiencing symptoms, with one or more risk factors and/or a prior history of IHD, are more likely to be experiencing ischemia.
Few objective indicators exist that provide definitive support for the diagnosis of AMI at the worksite. Thus, the nurse must be alert for more subtle cues of AMI. The individual may appear pale, diaphoretic, or anxious. The degree to which an individual's vital signs are affected may vary depending on the time since onset of ischemia and the extent of myocardial damage. Blood pressure usually decreases and then temporarily increases along with heart rate. This increase is a result of reflexive activation of the sympathetic nervous system (Haak, 1996) . Abnormal heart sounds (S3 and S4) indicate left ventric-200 ular dysfunction. However, these sounds usually are not present with initial symptoms. An elevation in temperature usually occurs 24 hours after tissue necrosis and reflects the inflammatory process.
Nurses with the capacity to conduct 12 lead ECGs at the worksite who strongly suspect an AMI is in progress need to access the EMS immediately. When keeping the person at rest and while waiting EMS arrival, the nurse could perform a 12 lead ECG to provide additional information to EMS personnel and, ultimately, the treating health care provider. In all other cases, the nurse needs to weigh the benefits and risks of performing an ECG as part of the initial assessment. The risk is that this procedure takes up time that may be more appropriately spent in accessing the EMS. In addition, the ECG may not be diagnostic, even if the individual is actually experiencing AMI. The individual may have an underlying abnormality in the rhythm that makes interpretation difficult, or the changes may not yet be apparent on the first ECG. This is the reason serial ECGs and enzyme analysis are conducted to look for patterns. The quality of the ECG can be affected by a number of factors, including the correct placement of the leads, the contact between the electrode and the skin, client movement, and electrical interference. The benefit of an on site ECG is that it provides further information to assist in the interpretation of the individual's symptoms. Twelve lead ECG and corresponding myocardial areas are presented in Table 1 .
Management
Following assessment and determination that the employee may potentially be experiencing an AMI, prompt activation of the EMS is essential. Time is critical in reducing myocardial damage and the nurse must act quickly and systematically. Having a rehearsed institutional protocol may facilitate response time of all individuals involved (see Table 2 ). The nurse needs to instruct another employee to meet and direct the EMS personnel to the crisis location. The nurse can assist the employee to a comfortable lying position to reduce further myocardial oxygen demand. It is important to maintain an open airway and administer oxygen at 4 to 6 liters per nasal cannula, if it is available (American Heart Association, 1992). Monitoring the employee's vital signs is crucial. If a cardiac monitoring system is available (e.g., automatic external defibrillator) the nurse can apply, documenting the cardiac pattern.
Employees with prescribed nitroglycerin may take a tablet sublingually or metered spray. Systolic pressure should be > 110 mm Hg prior to each dose of nitroglycerine. Nitroglycerine may cause a significant vasodilitating effect. Therefore, monitoring for hypotension and withholding the nitroglycerine if the individual is hypotensive is extremely important. An individual may take up to three tablets/metered spray 5 minutes apart. If the individual has complete symptom relief with nitroglycerine, the symptoms are more likely to have been associated with an episode of angina. Individuals experiencing AMI are unlikely to experience relief with sublingual nitroglycerine. One common problem is that an individual's nitro- glycerin tablets may be ineffective if the bottle has been opened for more than 6 months or improperly stored. The response team should remain supportive of the individual and answer questions to reduce further anxiety and apprehension. The employee must not be left unattended. If the employee's condition deteriorates prior to the arrival of the EMS personnel, the nurse must be prepared to perform CPR. Worksites may have an automatic external defibrillator available. Automatic external defibrillators are devices that provide the first responder to the scene of a cardiac arrest with the capability of monitoring and rapid defibrillation. These are relatively simple devices which require only a small amount of training to use. The adhesive electrodes are applied to the chest, the device assesses the rhythm, charges the capacitor, and delivers the countershock(s) of electrical energy for ventricular fibrillation or pulseless ventricular tachycardia. The rescuer does not need to interpret the rhythm with the use of this device. The advantage of the device is that if defibrillation is necessary, it can be delivered prior to the arrival of EMS personnel.
The nurse should provide the EMS with any pertinent information collected about the employee's health history, current episode, current medication, and allergies. In addition, information about any recent trauma may make the individual ineligible for thrombolytic therapy. In addition, if the employee has previous ECGs available, a copy of each should be provided to the EMS APRIL 1998, VOL. 46, NO.4 personnel. Comparing the ECG obtained during ischemia with a prior ECG provides valuable information.
Rehabilitation
When the client is released to return to work, the nurse can serve as a liaison with encouragement to continue the established exercise program and monitor the client's progress. If the employer provides a facility where employees can regularly exercise, the nurse can work closely with the employee to monitor current activities and incremental work load adjustments. With employee permission, cardiac rehabilitation staff make referrals to health clubs and employee gyms, providing nursing staff with information related to the client's current work load and areas of difficulty, along with recommendations for increasing work loads.
The nurse is actively involved in facilitating the employee's return to work. This needs to be individualized based on the employee's exercise capacity and job description. Most employees initially return to work on a limited schedule. Employees in physically active positions also may have weight and activity restrictions. The nurse needs to serve as a liaison between the health care provider and the employer to provide solutions that can accommodate the needs of the employee.
CONCLUSION
The nurse can make a significant contribution to Acute Myocardial Infarction in the Workplace.
Zerwic, J.J., & Prasun, M.A.
reducing morbidity and mortality associated with AMI in the workplace. Through a process of rapid assessment and decision to transport, individuals experiencing AMI will have the best chance to benefit by receiving reperfusion therapeutic modalities early in the course of infarction. Appropriate triage occurs as a result of the nurse's understanding of the pathophysiology of AMI, knowledge of the signs and symptoms, and through the use of protocols emphasizing rapid transport. In addition, the nurse can serve as a vital resource to employees in relation to health promotion and cardiac risk reduction. This can be accomplished by providing regular continuing educational opportunities about risk factor modification (e.g., smoking cessation, low fat diet, blood pressure control, and regular exercise), symptom recognition, and providing CPR training to as many members of the work force as possible. These strategies will ultimately be cost effective for employers by reducing the morbidity and mortality associated with heart disease.
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3. AAOHN Jou17Ul11998; 46(4), 195-202. Cardiovascular disease is a leading cause of death in the United States. Significant numbers of individuals in the work force experience an acute myocardial infarction (AMI) each year.
Strategies are available that can be used to facilitate rapid assessment and management of the employee suspected of having AMI.
The occupational health nurse can make a significant contribution in reducing the morbidity and mortality associated with AMI through the development of a system for rapid assessment and activation of the emergency medical system.
